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Abstract 
Spinal and bulbar muscle atrophy (SBMA) is an X-linked neuromuscular disorder caused by CAG repeat 
expansions in the androgen receptor (AR) gene. The SBMA phenotype consists of slowly progressive 
neuromuscular symptoms and undermasculinization features as the result of malfunction of the AR. The latter 
mainly includes gynecomastia and infertility.  Hypospadias is also a feature of undermasculinization with an 
underdeveloped urethra and penis, it has not been described as part of the SBMA phenotype but has been 
suggested to be associated with a prolonged CAG repeat in the AR gene. 
This study includes the first epidemiologic description of the co-occurrence of hypospadias and SBMA in 
subjects and their male relatives in Swedish population-based health registers, as well as an additional clinical 
case.  
One boy with severe hypospadias was screened for mutations in the AR gene and was found to have 42 CAG 
repeats in it, which is in the full range of mutations causing SBMA later in life. We also detected a maximum of 
four cases displaying the combination of SBMA and hypospadias in our national register databases. 
This is the third case report with hypospadias in association with CAG repeat expansions in the AR gene in the 
full range known to cause SBMA later in life. Our findings suggest that hypospadias may be an under diagnosed 
feature of the SBMA phenotype and we propose that neurologists working with SBMA further investigate and 
report the true prevalence of hypospadias among patients with SBMA.   
 3 
Introduction  
Spinal bulbar muscle atrophy (SBMA), also known as Kennedy’s syndrome, is an X-linked neuromuscular 
disorder caused by pathological CAG expansions, due to unequal crossing-over events, in the androgen receptor 
(AR) gene [1, 2]. Alleles of ≥ 38 CAG repeats in this gene have full penetrance compared to the normal range of 
up to 34 repeats. Alleles with 36–37 CAG repeats have reduced penetrance. [3] The SBMA phenotype consists 
of a combination of androgen insensitivity features that become apparent during adolescence and a slowly 
progressive neurological syndrome starting during adulthood. The latter includes muscle weakness with atrophy 
and postural tremor [3, 4]. The symptoms of SBMA are similar to those of other neuromuscular disorders and, 
historically, have been misdiagnosed as amyotrophic lateral sclerosis (ALS). However, in contrast to ALS, 
SBMA does not affect life expectancy. 
As in other polyglutaminopathies, there is an inverse relationship between the number of CAG repeats and the 
age of onset of the neurological features [5, 6]. The CAG expansion in the AR gene causes a decreased function 
of the androgen receptor, resulting in symptoms of undermasculinization, e.g., gynecomastia, erectile 
dysfunction, and infertility [7]. 
Hypospadias is a common malformation with an increasing incidence and is found in 1 out of 125 boys in 
Sweden [8]. It is a symptom of undermasculinization with the urethral opening located on the downside of the 
penis, or in the scrotum or perineum in severe cases. Thus, hypospadias is often a part of male disorders of 
sexual development (DSD). The degree of severity of hypospadias depends on the timing of the arrest of urethral 
development, which spans between fetal weeks 8 and 16. The condition is generally a complex genetic disorder, 
but some cases may be caused by point mutations in different genes, especially those involved in androgen 
synthesis or metabolism. 
The androgen receptor gene (AR) is active during male sex development and mutations in the gene cause 
androgen insensitivity syndrome (AIS). The AIS spectrum is rather broad and spans from the mild partial (PAIS) 
to the complete insensitivity syndrome (CAIS) in XY females [9]. A few studies have described an association 
between longer CAG repeats in the AR gene and different forms of undermasculinization, such as in prostate 
cancer, infertility, hypospadias, and microphallus [10-13]. However, the ranges of repeats were all still in the 
normal range of previous reports. Interestingly, in 2001, there was a report on one boy with severe hypospadias 
and 44 CAG repeats in the AR gene, which is well above the normal range [14]. Recently, another patient with 
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SBMA was reported to have an extremely prolonged expansion of 68 CAG repeats and a past history of chordee, 
which motivated surgery at the age of seven [15]. 
Here we report on another boy with severe hypospadias associated with a pathological AR gene expansion 
compatible with SBMA. We also use an epidemiological approach to describe the occurrence of hypospadias 
and SBMA in subjects and their male relatives. 
Material and methods 
Case report 
A Swedish boy was diagnosed with severe hypospadias at birth. There was no family history of AIS or 
neuromuscular disorders. We performed a routine mutation analysis for DSD in five genes and only identified a 
pathological expansion of 42 CAG repeats in exon 1 in the AR gene. This is a full range mutation known to 
cause SBMA later in life. The patient´s mother was also tested for this mutation after genetic counseling and was 
found to be a carrier of this expansion. 
National registers 
Sweden has a renowned system of records for citizens in which demographic and healthcare data are collected 
continuously. Permanent residents are given personal identity numbers that enable linkage between the registers. 
The Swedish National Board of Health and Welfare has collected information on inpatients at public Swedish 
hospitals in the National Patient Register (PAR) since the 1960s. This register has nationwide coverage from 
1987 and onwards and includes outpatient visits since 2001. Since 1973 the Board has maintained the nationwide 
Medical Birth Registry (MBR) of all pregnancies resulting in childbirth. The MBR also includes information on 
congenital malformations. The Multi-Generation Register (MGR) is made up of individuals registered in Sweden 
at some time since 1961 and those who were born at some time since 1932; these individuals are called index 
persons. The register enables linkage between index persons and their biological parents and thereby also 
enables linkage between siblings. 
The PAR and MBR were screened for the occurrence of (1) individuals diagnosed with motor neuron diseases 
(PAR) and hypospadias (MBR and PAR); (2) individuals diagnosed with hypospadias and having male first- and 
second-degree relatives on the maternal side (identified through the MGR) with motor neuron disease. The 
relatives were found by first identifying the patient’s mother and then her father and brothers in the MGR. Codes 
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from the International Classification of Diseases (ICD) -8, -9 and -10 were used in analyses. There is no specific 
ICD code for SBMA and therefore the following codes covering motor neuron disease were included: ICD-10: 
G12.2, ICD-9: 335W, 335X, ICD-8: 348.9. Due to the uncertainty in coding of SBMA, additional information on 
all other diagnoses, survival time after diagnosis, and cause of death were collected from the PAR and the Cause 
of Death Registry (CDR) in order to exclude potentially misdiagnosed or uncertain cases of SBMA and patients 
with ALS. Exclusion criteria are presented in Table 1. 
The regional Ethical Review Board in Stockholm, Sweden, granted permission for the study and all individuals’ 
information was anonymized and de-identified prior to analysis. 
Results 
Data from the national patient registers 
Several male patients diagnosed with both motor neuron disease and hypospadias were identified. However, only 
one potential case with suspected SBMA remained after considering clinical factors that could arouse suspicion 
of amyotrophic lateral sclerosis (ALS) or misdiagnosis, described in table 1. Fifteen cases of potential SBMA 
were found among the male first- and second-degree relatives of patients with hypospadias identified through the 
MGR. The majority met the exclusion criteria, however, and only three possible cases of SBMA remained 
among the relatives of patients with hypospadias, taking the X-linked inheritance into account. 
Discussion 
The undermasculinization symptoms reported to occur in SBMA are gynecomastia, difficulties in growing a 
beard, testicular atrophy, erectile dysfunction, and/or infertility. Previously, a significantly higher number of 
CAG repeats in the AR gene within the normal range has been identified in boys with hypospadias [12, 13]. This 
is the third report of hypospadias/chordee in a subject carrying a pathological CAG expansion in the AR gene, 
which is in the full range of mutations known to cause SBMA later in life. 
In our setting, we perform mutation analyses of several genes, including the AR gene, as part of routine DSD 
investigations. Our aim is to identify both point mutations in the AR gene, as well as to determine the number of 
CAG repeats since both findings are known risk factors for hypospadias. Revealing the genetic causes of DSD 
children is of benefit for the parents since the information about future gender identity, long-term prognosis, and 
the risk of recurrence can be given with much more accuracy. Furthermore, finalizing a diagnosis may also be 
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crucial for gender assignment in some cases and for early treatment management, as well as for genetic 
counseling. The decision to include the CAG expansion analysis in DSD is not deprived of important 
implications for genetic counseling, as this case illustrates. The expansion of CAG repeats within the normal 
range is part of the known genetic background of hypospadias. SBMA is a late-onset incurable disorder with 
slow progression, and it can be debated whether it is beneficial for the family to acquire this knowledge early on. 
SBMA is also a very rare disorder and the association between hypospadias and, so far, SBMA has not been 
acknowledged in the neurological community (Professor La Spada, personal communication). Our findings add 
observational evidence supporting the possibility of an association between SBMA and hypospadias. We also 
believe that it is easy to miss a surgical history of hypospadias repair in a grown-up male who is being evaluated 
for a neurological disorder. In addition, corrective surgery is mostly performed at a young age – nowadays 
around one year of age, and thus the patient may not be aware of this congenital malformation himself. 
An inherent weakness of performing epidemiological studies from national registers on SBMA is that there is no 
specific ICD code for this disorder. We had to make a clinical evaluation of each case in order to exclude, in 
particular, ALS and to consider the age of onset and outcome. In addition, SBMA is a very rare disorder with an 
estimated prevalence of 1 in 50,000 males [3]. Using the Multi-Generation Register, we also analyzed whether or 
not hypospadias was more common among relatives, considering an X-linked inheritance (maternal uncles or 
grandfathers). Altogether, one additional male with this combination and possibly three families with an 
association between hypospadias and SBMA in different individuals could be detected. 
A higher incidence of SBMA in Scandinavia has been reported. First, after molecular diagnostic methods made 
it possible to diagnose SBMA in the Wasa region in Finland, the incidence was unexpectedly found to be 13 
patients per 85,000 inhabitants. This exceeded the local prevalence of ALS by two indicating that SBMA was 
under diagnosed [16]. In another study, a founder effect in SBMA was detected in Scandinavia with a common 
haplotype encompassing the CAG repeat on the X-chromosome [17]. It was surmised that the Scandinavian 
mutation was introduced in Western Finland 20 generations ago. The number of CAG repeats within the 
haplotype has slipped during generations and varies between 38 and 51, with a majority of individuals with 44 or 
45 repeats. The meiotic stability between generations is high in crossing-over events, but, in SBMA, a change in 
the number of repeats has been demonstrated to occur in 27% of meiosis, which may explain the variation of 
repeats in the Scandinavian population [6]. 
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From these calculations, it is impossible to accurately evaluate the association between SBMA and hypospadias. 
However, we speculate that hypospadias may be an under diagnosed feature of the SBMA phenotype. Our report 
contributes to broadening of the phenotype characterization of SBMA. Hypospadias is not an unexpected finding 
in the context of SBMA since it is a well-known feature of undermasculinization. We encourage other physicians 
to report cases similar to ours in order to establish the true prevalence of hypospadias in SBMA. Additional cases 
will also contribute to further establishing the possible correlation between the numbers of CAG repeats in the 
AR gene and the severity of the hypospadias phenotype. 
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Table 1. 
 
 
Exclusion criteria 
 
<6 years follow-up 
Deceased <6 years after first diagnosis 
Diagnosis at <20 or >65 years of age 
Motor neuron disease as death cause 
Presence of additional neurological diagnoses 
Stroke (prior SBMA diagnose) 
Late effects of cerebrovascular disease 
Multiple sclerosis 
ALS (after SBMA diagnose) 
 
 
